(Q42455114)

English

Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

scientific article published on May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

0 references

1 reference

based on heuristic

inferred from title

5

object named as

Agid Y

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

author name string

Murer MG

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Dziewczapolski G

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Menalled LB

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

García MC

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Gershanik O

6

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Raisman-Vozari R

7

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Annals of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

561-575

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Mortality of patients with parkinson's disease treated with levodopa

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Levodopa in Parkinson disease: a long-term appraisal of mortality

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Does levodopa therapy delay death in Parkinson's disease? A review of the evidence.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Neurotoxicity of levodopa on catecholamine-rich neurons

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Protective effect of carbidopa on hydroxyl radical generation in the rat striatum by dopamine.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Differential effects of chronic L-dopa treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Excitotoxicity of L-dopa and 6-OH-dopa: implications for Parkinson's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

L-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

The effect ofl-DOPA and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiography

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Differential regional effects of long-term L-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Expression of neurotrophins by midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Reinnervation after destruction of the dopaminergic system in the rat nucleus accumbens: a quantitative immunohistochemical analysis.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disea

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Dopamine increases the expression of tyrosine hydroxylase and aromatic amino acid decarboxylase in primary cultures of fetal neurons

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Brain-derived neurotrophic factor and neurotrophin-4/5 modify neurotransmitter-related gene expression in the 6-hydroxydopamine-lesioned rat striatum

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

The free radical hypothesis in idiopathic parkinsonism: evidence against it

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Selegiline and mortality in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FANA.410430504

21 January 2018

Identifiers

10.1002/ANA.410430504

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42455114&oldid=1958083563"